Lexicon Pharmaceuticals, INC Schedule 13D activist filings

Major shareholders of Lexicon Pharmaceuticals have converted preferred stock into over 20 million common shares, bringing their collective ownership to 51.1%.

Lexicon Pharmaceuticals, Inc. announced a significant equity financing round, including a public offering and private placements, raising over $58 million from major shareholders and institutional investors.